Cargando…
Vaccine-mediated protection against Campylobacter-associated enteric disease
Campylobacter coli and Campylobacter jejuni are responsible for 400 million to 500 million cases of enteric disease each year and represent the most common cause of bacterial gastroenteritis worldwide. Despite its global importance, Campylobacter vaccine development has been hampered by the lack of...
Autores principales: | Quintel, Benjamin K., Prongay, Kamm, Lewis, Anne D., Raué, Hans-Peter, Hendrickson, Sara, Rhoades, Nicholas S., Messaoudi, Ilhem, Gao, Lina, Slifka, Mark K., Amanna, Ian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314533/ https://www.ncbi.nlm.nih.gov/pubmed/32637610 http://dx.doi.org/10.1126/sciadv.aba4511 |
Ejemplares similares
-
Campylobacter vaccination reduces diarrheal disease and infant growth stunting among rhesus macaques
por: Hendrickson, Sara M., et al.
Publicado: (2023) -
Reduced infant rhesus macaque growth rates due to environmental enteric dysfunction and association with histopathology in the large intestine
por: Hendrickson, Sara M., et al.
Publicado: (2022) -
Growth faltering regardless of chronic diarrhea is associated with mucosal immune dysfunction and microbial dysbiosis in the gut lumen
por: Rhoades, Nicholas S., et al.
Publicado: (2021) -
Maturation of the infant rhesus macaque gut microbiome and its role in the development of diarrheal disease
por: Rhoades, Nicholas, et al.
Publicado: (2019) -
Taxonomic and Functional Shifts in the Perinatal Gut Microbiome of Rhesus Macaques
por: Rhoades, Nicholas S., et al.
Publicado: (2022)